The Global Optic Nerve Glioma Market is expected to reach US$ 350 million by 2023, and the market is projected to grow at a CAGR of ~ 3.2 % during the forecast period 2017-2023.
Optic nerve glioma or optic glioma or juvenile pilocytic astrocytoma are kinds of brain tumor at the entire affecting the optic nerve cells. Optic nerve gliomas are gradual growing, unusual and widely talking determined in children. Its prevalence in humans over age 20 is quite uncommon and any incidence is related to the genetic sickness neurofibromatosis kind 1, or nf1 in about 30% of the instances. Signs and symptoms of an optic nerve glioma are nausea and vision disturbances, vomiting, stability troubles, involuntary eye actions, memory impairment, delay in increase and lots of others.
Sunlight hour’s sleepiness is likewise witnessed in a large kind of sufferers. The strain exerted with the aid of those tumors might also additionally reason secondary results which includes hormonal issues due to effects at the pituitary gland. Optic nerve gliomas account for about 1% of all intracranial tumors. approximately 10% of optic nerve gliomas are located inside an optic nerve, one zero.33 in each optic nerve and chiasm (left and proper optic nerve crossing), and about one 1/three incorporate the chiasm itself. The last one fourth optic nerve gliomas are in the hypothalamus and approximately 5 5% gliomas are multi-centric.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4152 .
The remedy of optic nerve gliomas consist of surgical treatment and radiation remedy. The drawbacks of surgical treatment include high risk of mind harm and high charges. Surgical operation may not continually be a good alternative because of location of the tumour. Radiation therapy for optic nerve gliomas has its very own drawbacks inclusive of harm to the eyes and mind, high charges and other aspect outcomes associated with its use which include vomiting, reduced immunity, hair loss and so on.
Some of key players profiled in the report are Emcure Pharmaceuticals ltd., Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Pfizer Inc., Taj Pharmaceuticals Limited, Novartis International AG, Teva Pharmaceutical Industries Ltd, GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation and others.
The Global Optic Nerve Glioma Market has been segmented on the basis of types, diagnosis, treatment and end users.
Based on types, the market has been segmented as malignant optic nerve glioma and benign optic nerve glioma. Based on the diagnosis, the market has been segmented into neurological exam, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), biopsy and others.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/4152 .
Based on the treatment, the market has been segmented into surgery, radiation therapy, chemotherapy and others. Based on the end users, the market has been segmented as pharmace hospitals and clinics, diagnostic centers and others.
1 Report Prologue
2 Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/4152 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –